查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1829846

2025年全球植入式神經刺激設備市場報告

Implantable Neurostimulation Devices Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，植入式神經刺激設備市場快速擴張，市場規模從2024年的50.2億美元成長至2025年的56.2億美元，複合年成長率為11.8%。預測期內的成長歸因於非藥物治療需求的不斷成長、微創手術需求的不斷成長、老年人口的成長、各種精神疾病患病率的不斷上升以及慢性病患病率的不斷上升。

預計未來幾年植入式神經刺激設備市場將快速成長，到2029年將達到88.6億美元，複合年成長率為12.1%。預測期內的成長歸因於神經系統疾病盛行率的上升、文明病盛行率的上升、認知度的提高、脊髓損傷發生率的上升以及醫療保健支出的增加。預測期內的主要趨勢包括感測和神經刺激技術的不斷進步、技術先進的產品、閉合迴路系統的整合以及無線技術的整合。

植入式神經刺激設備是醫療設備，旨在向神經系統的特定部位傳遞電刺激，以治療各種神經和心理疾病。這些裝置透過手術植入體內，調節神經活動，為單靠藥物無法充分治療的疾病提供了一種先進的治療方法，從而改善患者的生活品質。

植入式神經刺激設備的主要類型包括脊髓刺激 (SCS)、胃電刺激 (GES)、深部腦部刺激 (DBS)、薦椎神經刺激(SNS) 和迷走神經刺激 (VNS)。脊髓刺激 (SCS) 療法利用弱電流阻斷疼痛訊號到達大腦，有效治療慢性疼痛。這些裝置用於治療疼痛、帕金森氏症、尿失禁、大便失禁、癲癇和胃輕癱。它們的終端使用者多種多樣，包括醫院、診所和門診手術中心。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備行業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要重新認證醫療設備，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供植入式神經刺激設備的市場統計數據，例如全球市場規模、區域佔有率、競爭對手的市場佔有率、詳細的植入式神經刺激設備神經刺激設備市場、市場趨勢和機遇，以及神經刺激設備在神經刺激設備行業取得成功所需的數據。本植入式神經刺激設備市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切觀點。

我們預測未來五年該市場將成長12.1%，較先前預測略有下降0.2%。下降主要源自於美國與其他國家之間關稅的影響。這可能會透過對來自奧地利和丹麥等主要地區的定向導線陣列和可充電電源徵收關稅直接影響美國，從而導致運動障礙的治療選擇減少，神經調節療法的成本上升。此外，這種影響可能透過互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響，更為廣泛地顯現。

神經系統疾病的日益普及預計將推動植入式神經刺激設備市場的未來成長。神經系統疾病會影響神經系統的結構和功能，導致各種症狀，包括癱瘓、癲癇和認知障礙。高血壓、發育異常以及創傷和損傷等因素會導致這些疾病的發生率上升。當其他治療方法無效或不足時，植入式神經刺激設備可用於調節神經活動並緩解症狀。例如，美國非營利組織阿茲海默症症協會報告稱，到 2024 年，約有 690 萬 65 歲及以上的美國將患上阿茲海默症，其中 73% 的 75 歲及以上人群將患有該病。預計到 2050 年，這一數字將增至 1,270 萬。因此，神經系統疾病的日益普及預計將推動植入式神經刺激設備市場的成長。

植入式神經刺激設備市場的主要參與者正在開發先進技術，例如脊髓刺激 (SCS) 系統，以治療慢性疼痛。 SCS 系統是醫療設備，它使用電脈衝調節脊髓神經活動，在其他治療方法無效時緩解疼痛並改善患者的生活品質。例如，2022 年 12 月，美國醫療設備製造商雅培 (Abbott) 的 Eterna 脊髓刺激 (SCS) 系統獲得了 FDA核准。 Eterna SCS 是市面上最小的可充電植入式脊髓刺激設備，旨在最大限度地提高舒適度。它採用雅培的 BurstDR 刺激技術，該技術可複製自然的腦放電模式以增強疼痛緩解，與傳統的刺痛刺激相比，87% 的患者更喜歡它。 Eterna 的 Xtend 能量技術每年只需充電五次，其 TotalScan 技術使其與全身 MRI 掃描相容。它還可以適應未來的發展而無需更換。與雅培行動應用程式的整合使用戶可以在 iPhone 裝置上即時追蹤電池壽命和充電狀態。

2023年9月，總部位於英國的神經調節療法提供者Amber Therapeutics收購了BioInduction，收購金額未揭露。此次收購為Amber提供了寶貴的硬體、專業知識和製造經驗，加速了Amber-UI的開發和商業化。 BioInduction是一家總部位於英國的製造商，專注於植入式神經刺激設備。

植入式神經刺激設備市場涵蓋響應式神經刺激系統、周邊神經刺激系統、腦脊髓液分流系統和電療設備的銷售。該市場的價值指的是“出廠價”，即產品製造商或生產商向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向最終客戶銷售的產品價值。該市場的產品價值還包括產品製造商提供的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球植入式神經刺激設備：PESTEL分析（政治、社會、科技、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球植入式神經刺激設備市場：成長率分析
  • 全球植入式神經刺激設備市場表現：規模與成長，2019-2024
  • 全球植入式神經刺激設備市場預測：規模與成長，2024-2029，2034
  • 全球植入式神經刺激設備：總目標市場（TAM）

第6章 市場細分

  • 全球植入式神經刺激設備市場類型、表現及預測（2019-2024、2024-2029、2034）
  • 脊髓刺激（SCS）
  • 胃電刺激（GES）
  • 深部腦部刺激（DBS）
  • 薦椎神經刺激（SNS）
  • 迷走神經刺激（VNS）
  • 其他類型
  • 全球植入式神經刺激設備市場應用、效能及預測（2019-2024、2024-2029、2034）
  • 疼痛管理
  • 帕金森氏症
  • 尿失禁和大便失禁
  • 癲癇
  • 胃輕癱
  • 其他用途
  • 全球植入式神經刺激設備市場（按最終用戶、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 診所
  • 門診手術中心
  • 全球植入式神經刺激設備市場：脊髓刺激（SCS）細分、類型、表現及預測，2019-2024年、2024-2029年、2034年
  • 可充電 SCS 設備
  • 不可充電的SCS設備
  • 全球植入式神經刺激設備市場：按胃電刺激 (GES) 細分、類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 植入式胃刺激裝置
  • 可調式胃刺激器
  • 全球植入式神經刺激設備市場：按深部腦部刺激 (DBS) 細分、類型、表現和預測，2019-2024 年、2024-2029 年、2034 年
  • 治療運動障礙的DBS設備
  • 用於治療精神疾病的DBS設備
  • 全球植入式神經刺激設備市場：按骶薦椎神經刺激(SNS) 細分、類型、表現和預測，2019-2024 年、2024-2029 年、2034 年
  • 尿失禁治療儀
  • 用於治療大便失禁的SNS裝置
  • 全球植入式神經刺激設備市場：迷走神經刺激 (VNS) 細分、類型、表現及預測，2019-2024 年、2024-2029 年、2034 年
  • 用於治療癲癇的迷走神經刺激裝置
  • 治療憂鬱症的迷走神經刺激裝置
  • 全球植入式神經刺激設備市場：按類型、其他、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 周邊神經刺激（PNS）
  • 皮層刺激器
  • 新的神經刺激技術

第7章 區域和國家分析

  • 全球植入式神經刺激設備市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球植入式神經刺激設備市場：國家、績效及預測（2019-2024、2024-2029、2034）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 植入式神經刺激設備市場：競爭格局
  • 植入式神經刺激設備市場：公司簡介
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Dignity Health Overview, Products and Services, Strategy and Financial Analysis
    • St. Jude Medical LLC Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • LivaNova PLC
  • Nevro Corp.
  • Axonics Inc.
  • NeuroPace Inc.
  • Bioness Inc.
  • Saluda Medical Pty Ltd.
  • SceneRay Co. Ltd.
  • NeuroMetrix Inc.
  • CURE Epilepsy
  • Synapse Biomedical Inc.
  • NeuroSigma Inc.
  • Nuvectra Corporation
  • MicroTransponder Inc.
  • Pain Management NYC
  • Curonix LLC

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年植入式神經刺激設備市場：提供新機會的國家
  • 2029年植入式神經刺激設備市場：細分市場帶來新機會
  • 2029年植入式神經刺激設備市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r31973u

Implantable neurostimulation devices are medical devices designed to deliver electrical stimulation to specific areas of the nervous system to treat various neurological and psychological conditions. These devices are surgically implanted into the body to modulate nerve activity, offering a sophisticated approach for managing conditions that may not respond adequately to medication alone, thereby enhancing patients' quality of life.

The primary types of implantable neurostimulation devices include spinal cord stimulation (SCS), gastric electric stimulation (GES), deep brain stimulation (DBS), sacral nerve stimulation (SNS), vagus nerve stimulation (VNS), and others. Spinal cord stimulation (SCS) therapy uses mild electrical currents to block pain signals from reaching the brain, providing effective management for chronic pain conditions. These devices are applied in treating pain management, Parkinson's disease, urinary and fecal incontinence, epilepsy, gastroparesis, and other conditions. They are used by various end-users, including hospitals, clinics, and ambulatory surgical centers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The implantable neurostimulation devices market research report is one of a series of new reports from The Business Research Company that provides implantable neurostimulation devices market statistics, including implantable neurostimulation devices industry global market size, regional shares, competitors with a implantable neurostimulation devices market share, detailed implantable neurostimulation devices market segments, market trends and opportunities, and any further data you may need to thrive in the implantable neurostimulation devices industry. This implantable neurostimulation devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The implantable neurostimulation devices market size has grown rapidly in recent years. It will grow from $5.02 billion in 2024 to $5.62 billion in 2025 at a compound annual growth rate (CAGR) of 11.8%. The growth in the historic period can be attributed to increasing demand for non-pharmacological treatments, growing demand for minimally invasive procedures, growing geriatric population, increasing the wide range of psychiatric disorders, and increasing incidence of chronic diseases.

The implantable neurostimulation devices market size is expected to see rapid growth in the next few years. It will grow to $8.86 billion in 2029 at a compound annual growth rate (CAGR) of 12.1%. The growth in the forecast period can be attributed to rising prevalence of neurological disorders, rise in prevalence of lifestyle diseases, rising awareness, increase in spinal cord injuries, and increasing healthcare expenditure. Major trends in the forecast period include sensing technology, increasing advances in neurostimulation technologies, technologically advanced products, incorporating closed-loop systems, and integrating wireless technology.

The forecast of 12.1% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on directional lead arrays and rechargeable power units, sourced from key regions such as Austria and Denmark, which could lead to reduced treatment options for movement disorders and higher costs for neuromodulation therapies.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of neurological disorders is anticipated to drive the growth of the implantable neurostimulation device market in the future. Neurological disorders are conditions that impact the structure or function of the nervous system, leading to a range of symptoms such as paralysis, seizures, and cognitive impairments. Factors such as high blood pressure, developmental abnormalities, and trauma or injury contribute to higher detection rates of these disorders. Implantable neurostimulation devices are utilized to modulate nerve activity and alleviate symptoms when other treatments prove ineffective or insufficient. For example, in 2024, the Alzheimer's Association, a US-based non-profit organization, reported that approximately 6.9 million Americans aged 65 and older are living with Alzheimer's disease, with 73% being 75 years or older. This figure is projected to increase to 12.7 million by 2050. Consequently, the rising prevalence of neurological disorders is expected to propel the growth of the implantable neurostimulation device market.

Key players in the implantable neurostimulation devices market are developing advanced technologies, such as spinal cord stimulation (SCS) systems, to address chronic pain conditions. An SCS system is a medical device that uses electrical impulses to modulate nerve activity in the spinal cord, providing pain relief and improving patient quality of life when other treatments fail. For instance, in December 2022, Abbott, a U.S.-based medical device company, received FDA approval for the Eterna spinal cord stimulation (SCS) system. The Eterna SCS is the smallest rechargeable implantable spinal cord stimulator on the market, designed for maximum comfort. It features Abbott's BurstDR stimulation technology, which replicates natural brain firing patterns for enhanced pain relief and is preferred by 87% of patients over traditional tingling stimulation. Eterna requires as few as five recharges annually due to Xtend energy technology and supports full-body MRI scans with TotalScan technology. It is also adaptable to future advancements without replacement. Abbott's mobile app integration allows real-time tracking of battery life and charging status on iPhone devices.

In September 2023, Amber Therapeutics, a UK-based provider of neuromodulation therapies, acquired Bioinduction for an undisclosed amount. This acquisition gives Amber access to valuable hardware, expertise, and manufacturing experience, accelerating the development and commercialization of Amber-UI. Bioinduction is a UK-based manufacturer specializing in implantable neurostimulation devices.

Major companies operating in the implantable neurostimulation devices market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Dignity Health, St. Jude Medical LLC, LivaNova PLC, Nevro Corp., Axonics Inc., NeuroPace Inc., Bioness Inc., Saluda Medical Pty Ltd., SceneRay Co. Ltd., NeuroMetrix Inc., CURE Epilepsy, Synapse Biomedical Inc., NeuroSigma Inc., Nuvectra Corporation, MicroTransponder Inc., Pain Management NYC, Curonix LLC

North America was the largest region in the implantable neurostimulation devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the implantable neurostimulation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the implantable neurostimulation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The implantable neurostimulation devices market consists of sales of responsive neurostimulation systems, peripheral nerve stimulation systems, cerebral spinal fluid shunt systems and electroceutical devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Implantable Neurostimulation Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on implantable neurostimulation devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for implantable neurostimulation devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The implantable neurostimulation devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Spinal Cord Stimulation (SCS); Gastric Electric Stimulation (GES); Deep Brain Stimulation (DBS); Sacral Nerve Stimulation (SNS); Vagus Nerve Stimulation (VNS); Other Types
  • 2) By Application: Pain Management; Parkinson's Disease; Urinary And Fecal Incontinence; Epilepsy; Gastroparesis; Other Applications
  • 3) By End-User: Hospitals; Clinics; Ambulatory Surgical Centers
  • Subsegments:
  • 1) By Spinal Cord Stimulation (SCS): Rechargeable SCS Devices; Non-Rechargeable SCS Devices
  • 2) By Gastric Electric Stimulation (GES): Implantable Gastric Stimulators; Adjustable Gastric Stimulators
  • 3) By Deep Brain Stimulation (DBS): DBS Devices for Movement Disorders; DBS Devices for Psychiatric Disorders
  • 4) By Sacral Nerve Stimulation (SNS): SNS Devices for Urinary Incontinence; SNS Devices for Fecal Incontinence
  • 5) By Vagus Nerve Stimulation (VNS): VNS Devices for Epilepsy; VNS Devices for Depression
  • 6) By Other Types: Peripheral Nerve Stimulation (PNS); Cortical Stimulation Devices; Novel Neurostimulation Technologies
  • Companies Mentioned: Abbott Laboratories; Medtronic PLC; Boston Scientific Corporation; Dignity Health; St. Jude Medical LLC; LivaNova PLC; Nevro Corp.; Axonics Inc.; NeuroPace Inc.; Bioness Inc.; Saluda Medical Pty Ltd.; SceneRay Co. Ltd.; NeuroMetrix Inc.; CURE Epilepsy; Synapse Biomedical Inc.; NeuroSigma Inc.; Nuvectra Corporation; MicroTransponder Inc.; Pain Management NYC; Curonix LLC
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Implantable Neurostimulation Devices Market Characteristics

3. Implantable Neurostimulation Devices Market Trends And Strategies

4. Implantable Neurostimulation Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Implantable Neurostimulation Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Implantable Neurostimulation Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Implantable Neurostimulation Devices Market Growth Rate Analysis
  • 5.4. Global Implantable Neurostimulation Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Implantable Neurostimulation Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Implantable Neurostimulation Devices Total Addressable Market (TAM)

6. Implantable Neurostimulation Devices Market Segmentation

  • 6.1. Global Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Spinal Cord Stimulation (SCS)
  • Gastric Electric Stimulation (GES)
  • Deep Brain Stimulation (DBS)
  • Sacral Nerve Stimulation (SNS)
  • Vagus Nerve Stimulation (VNS)
  • Other Types
  • 6.2. Global Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pain Management
  • Parkinson's Disease
  • Urinary And Fecal Incontinence
  • Epilepsy
  • Gastroparesis
  • Other Applications
  • 6.3. Global Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • 6.4. Global Implantable Neurostimulation Devices Market, Sub-Segmentation Of Spinal Cord Stimulation (SCS), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Rechargeable SCS Devices
  • Non-Rechargeable SCS Devices
  • 6.5. Global Implantable Neurostimulation Devices Market, Sub-Segmentation Of Gastric Electric Stimulation (GES), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Implantable Gastric Stimulators
  • Adjustable Gastric Stimulators
  • 6.6. Global Implantable Neurostimulation Devices Market, Sub-Segmentation Of Deep Brain Stimulation (DBS), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • DBS Devices for Movement Disorders
  • DBS Devices for Psychiatric Disorders
  • 6.7. Global Implantable Neurostimulation Devices Market, Sub-Segmentation Of Sacral Nerve Stimulation (SNS), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • SNS Devices for Urinary Incontinence
  • SNS Devices for Fecal Incontinence
  • 6.8. Global Implantable Neurostimulation Devices Market, Sub-Segmentation Of Vagus Nerve Stimulation (VNS), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • VNS Devices for Epilepsy
  • VNS Devices for Depression
  • 6.9. Global Implantable Neurostimulation Devices Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Peripheral Nerve Stimulation (PNS)
  • Cortical Stimulation Devices
  • Novel Neurostimulation Technologies

7. Implantable Neurostimulation Devices Market Regional And Country Analysis

  • 7.1. Global Implantable Neurostimulation Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Implantable Neurostimulation Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Implantable Neurostimulation Devices Market

  • 8.1. Asia-Pacific Implantable Neurostimulation Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Implantable Neurostimulation Devices Market

  • 9.1. China Implantable Neurostimulation Devices Market Overview
  • 9.2. China Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Implantable Neurostimulation Devices Market

  • 10.1. India Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Implantable Neurostimulation Devices Market

  • 11.1. Japan Implantable Neurostimulation Devices Market Overview
  • 11.2. Japan Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Implantable Neurostimulation Devices Market

  • 12.1. Australia Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Implantable Neurostimulation Devices Market

  • 13.1. Indonesia Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Implantable Neurostimulation Devices Market

  • 14.1. South Korea Implantable Neurostimulation Devices Market Overview
  • 14.2. South Korea Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Implantable Neurostimulation Devices Market

  • 15.1. Western Europe Implantable Neurostimulation Devices Market Overview
  • 15.2. Western Europe Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Implantable Neurostimulation Devices Market

  • 16.1. UK Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Implantable Neurostimulation Devices Market

  • 17.1. Germany Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Implantable Neurostimulation Devices Market

  • 18.1. France Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Implantable Neurostimulation Devices Market

  • 19.1. Italy Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Implantable Neurostimulation Devices Market

  • 20.1. Spain Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Implantable Neurostimulation Devices Market

  • 21.1. Eastern Europe Implantable Neurostimulation Devices Market Overview
  • 21.2. Eastern Europe Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Implantable Neurostimulation Devices Market

  • 22.1. Russia Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Implantable Neurostimulation Devices Market

  • 23.1. North America Implantable Neurostimulation Devices Market Overview
  • 23.2. North America Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Implantable Neurostimulation Devices Market

  • 24.1. USA Implantable Neurostimulation Devices Market Overview
  • 24.2. USA Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Implantable Neurostimulation Devices Market

  • 25.1. Canada Implantable Neurostimulation Devices Market Overview
  • 25.2. Canada Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Implantable Neurostimulation Devices Market

  • 26.1. South America Implantable Neurostimulation Devices Market Overview
  • 26.2. South America Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Implantable Neurostimulation Devices Market

  • 27.1. Brazil Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Implantable Neurostimulation Devices Market

  • 28.1. Middle East Implantable Neurostimulation Devices Market Overview
  • 28.2. Middle East Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Implantable Neurostimulation Devices Market

  • 29.1. Africa Implantable Neurostimulation Devices Market Overview
  • 29.2. Africa Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Implantable Neurostimulation Devices Market Competitive Landscape And Company Profiles

  • 30.1. Implantable Neurostimulation Devices Market Competitive Landscape
  • 30.2. Implantable Neurostimulation Devices Market Company Profiles
    • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Dignity Health Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. St. Jude Medical LLC Overview, Products and Services, Strategy and Financial Analysis

31. Implantable Neurostimulation Devices Market Other Major And Innovative Companies

  • 31.1. LivaNova PLC
  • 31.2. Nevro Corp.
  • 31.3. Axonics Inc.
  • 31.4. NeuroPace Inc.
  • 31.5. Bioness Inc.
  • 31.6. Saluda Medical Pty Ltd.
  • 31.7. SceneRay Co. Ltd.
  • 31.8. NeuroMetrix Inc.
  • 31.9. CURE Epilepsy
  • 31.10. Synapse Biomedical Inc.
  • 31.11. NeuroSigma Inc.
  • 31.12. Nuvectra Corporation
  • 31.13. MicroTransponder Inc.
  • 31.14. Pain Management NYC
  • 31.15. Curonix LLC

32. Global Implantable Neurostimulation Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Implantable Neurostimulation Devices Market

34. Recent Developments In The Implantable Neurostimulation Devices Market

35. Implantable Neurostimulation Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Implantable Neurostimulation Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Implantable Neurostimulation Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Implantable Neurostimulation Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer